{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"130"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"212"}],"units":"Participants"}],"description":"Number of patients alive at 1 year after transplant.","groups":[{"description":"Patients undergoing unrelated umbilical cord blood transplantation (UCBT) for hematologic malignancies treated with myeloablative preparative regimen comprising fludarabine phosphate, mycophenolate mofetil, filgrastim, cyclophosphamide, cyclosporine and fractionated total-body irradiation.","id":"OG000","title":"Unrelated UCBT for Blood Cancers"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"at 1 year","title":"Number of Participants Who Were Alive at 1 Year Transplant Overall Survival","type":"PRIMARY","unitOfMeasure":"Participants"}